Pure Global AI
LMHRA · Middle East & Africa

Liberia medical device regulatory resources

Every Liberia dataset, comparison, and AI workpaper we maintain — one entry point for the whole market.

4 free resources15/25 topics with records8 regulations trackedOct 2026 fees reviewed

Everything we track for Liberia

Explore questions and sources →

Common questions about changing a registered medical device in Liberia. Each question separates published rules from details still awaiting verification.

Structured regulatory requirements

Explore all 17 source-linked facts →

15 of 25 research dimensions currently covered · 1 official sources · latest verification 2026-10-28

Market entry

D01

Authority & regime

Verified
LMHRA promulgated the medical-device registration regulation under its 2010 Act
The declaration identifies the Liberia Medicines and Health Products Regulatory Authority as the issuing authority, acting under the LMHRA Act of 2010 with Board approval.
1 source-linked fact
Checked 2026-10-28
Open details →
D02

Legal basis & guidance

Verified
Regulation LMHRA-R-[MEDEV]-22-015, Version 01: medical-device registration framework
The published regulation establishes the medical device registration framework. Its cover gives an adoption date of 30 September 2022, while the declaration records promulgation on 20 April…
1 source-linked fact
Checked 2026-10-28
Open details →
D03

Device definition & scope

Verified
Published scope covers devices manufactured, imported, distributed, stored, sold and used in Liberia
Chapter I section 2 applies the regulation to medical devices manufactured, imported, distributed, stored, sold and used in Liberia. The regulation separately defines IVDs and expressly inc…
1 source-linked fact
Checked 2026-10-28
Open details →
D04

Classification rules

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D05

Registration pathways

Verified
Registration restriction, subject to the stated Class A exemption
Chapter II section 4.1 prohibits sale, manufacture, import, export, distribution and supply as a grant or gift of an unregistered medical device. Section 4.8 provides a conditional Class A…
1 source-linked fact
Checked 2026-10-28
Open details →
D06

Reliance & recognition

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D07

Economic-operator roles

Verified
A non-resident applicant appoints a local representative or agent
A non resident applicant must nominate a local representative or agent. A power of attorney, formal agreement or other official authorization establishes the appointment; the applicant rema…
1 source-linked fact
Checked 2026-10-28
Open details →
D08

Establishment, import & distribution

Verified
Device supply requires registration and premises and importer licences
Section 4.18.1.1 makes manufacture for sale, import and supply conditional on device registration, valid premises and importer licences issued by the Authority, and compliance with licence…
1 source-linked fact
Checked 2026-10-28
Open details →
D09

Dossier requirements

Verified
Application identifies the device, class, applicant and manufacturer and includes the prescribed fee and samples
Section 4.2 requires an application for a single device, group, family or system, a non refundable application fee and relevant samples or artwork. Required particulars include device name,…
1 source-linked fact
Checked 2026-10-28
Open details →
D10

Official forms & portals

Verified
Applications use the Authority's prescribed form through the applicant or local agent
Section 4.3 states that the applicant or appointed local agent submits the registration application to the Authority using the form format issued under the applicable guidelines. It does no…
1 source-linked fact
Checked 2026-10-28
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Class A dossier includes labels and instructions for use
Section 4.5 requires label copies for primary and secondary components, relevant system, family and accessory labels, instructions for use, and a patient information leaflet where applicabl…
1 source-linked fact
Checked 2026-10-28
Open details →
D12

QMS, audit & inspection

Verified
Risk-dependent QMS assessment and QMS certificate evidence
Table 2 normally exempts Class A from regulatory QMS audits except where sterility or measuring accuracy needs assurance. Higher risk classes require confidence in an appropriate QMS or an…
1 source-linked fact
Checked 2026-10-28
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
Electrical-safety certification for non-exempt active Class A devices
Electrical safety
Metrology or equivalent certificate for non-exempt measuring Class A devices
Metrology
2 maintained overlays · 1 related fact
Checked 2026-10-28
Open details →
D14

Fees

Unresolved
Registration fee — original words and figures conflict
Unresolved: words USD 350 / figures USD 300
1 maintained fee line
Checked 2026-10-28
Open details →
D15

Review clocks

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D16

Approval validity & renewal

Verified
Three-year registration term with annual fees and a 90-day advance renewal application
Section 4.13 states a three year registration term unless earlier suspended or revoked, prescribed annual retention and maintenance fees, and renewal application at least 90 days before exp…
1 source-linked fact
Checked 2026-10-28
Open details →

Lifecycle & post-market

D17

Change control

Verified
Variations use the prescribed notification form and the applicable variation requirements
Under section 4.17, the applicant notifies a variation using the Third Schedule application form and follows the variation regulation and fee rules in force at submission. This passage alon…
1 source-linked fact
Checked 2026-10-28
Open details →
D18

UDI, listing & traceability

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D19

Clinical investigation & performance

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D20

Special access & derogation

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D21

Manufacturer PMS

Unresolved

No source-verified answer is published for this dimension yet.

1 source-linked fact
Checked 2026-10-28
Open details →
D22

Vigilance & incident reporting

Verified
Local representative informs LMHRA immediately on relevant serious device problems
Section 3.2.1 requires the local representative to monitor marketed devices and inform the Authority immediately on detecting a problem such as a serious manufacturing defect that may endan…
1 source-linked fact
Checked 2026-10-28
Open details →
D23

Recall, FSCA & market surveillance

Verified
Local agent handles device recalls and market monitoring
Sections 3.2.1 and 4.4.1 assign the local representative or agent market monitoring, communication with the Authority, recall handling and technical support responsibilities. They do not es…
1 source-linked fact
Checked 2026-10-28
Open details →
D24

Advertising, claims & promotion

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →
D25

Submission communications & appeal

Verified
Written refusal reasons and an opportunity to be heard
On refusal to issue or amend registration, section 4.10.3 requires written reasons and an opportunity for the applicant to be heard. Section 4.16 separately conditions suspension or cancell…
1 source-linked fact
Checked 2026-10-28
Open details →

LMHRA registration fees in USD · reviewed 2026-10-28

Fee lineAmountProvenance
Registration fee — original words and figures conflictUnresolved: words USD 350 / figures USD 300Planning estimate

Official LMHRA rules and guidance · 8 of 8 documents linked to official sources

DOC-GDL-016, Version 01Guidelines for Emergency Use Authorization of Medical Products
RegistrationVerified
DOC-GDL-017, Version 01Guidelines for Exemption of Fees Payment to the Authority for Certain Products and Services
RegistrationVerified
DOC-GDL-008 — printed document-control codeGuidelines on Inspectorate and Post-Market Surveillance (PMS)
GMP/QMSVerified
An Act to Establish the Liberia Medicines and Health Products Regulatory Authority, 2010An Act to Establish the Liberia Medicines and Health Products Regulatory Authority
GeneralVerified
Continue with this market

Turn Liberia research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →
Country hubs in other markets

Other Middle East & Africa markets

DJ Fang
Entering the Liberia market?
Local representation, LMHRA submissions, and lifecycle maintenance — handled with an expert.
Pricing